/
Respiratory
159Diseases↗
2.6KPipeline Programs↗
743Active Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
4,509
clinical trials
Completed2,810 · 62%
Recruiting424 · 9%
Unknown status408 · 9%
Terminated356 · 8%
Not yet recruiting182 · 4%
Withdrawn172 · 4%
Other157 · 3%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
148programs
116programs
81programs
75programs
48programs
Landscape
Diseases
Asthma
Most programs783
Programs
175
Trials
86
Recruiting
Pre
142
P1
106
P2
350
P3
261
Appr
192
Most programs:
GSK
GSKLAM
Most trials0
Programs
705
Trials
8
Recruiting
Chronic Obstructive Pulmonary Disease
Highest activity442
Programs
133
Trials
35
Recruiting
Pre
89
P1
50
P2
171
P3
118
Appr
130
Most programs:GSK
GSKIdiopathic Pulmonary Fibrosis
5150 programs53 trialsApproved
Obstructive Sleep Apnea
1130 programs30 trialsApproved
COPD
512 programs133 trialsApproved
Sinusitis
86 programs49 trialsApproved
Acute Respiratory Distress Syndrome
2104 programs26 trialsApproved
Interstitial Lung Disease
368 programs46 trialsApproved
Chronic Rhinosinusitis
70 programs39 trialsApproved
Pulmonary Fibrosis
133 programs53 trialsApproved
Sleep Apnea
245 programs39 trialsApproved
Bronchiectasis
457 programs25 trialsApproved
Rhinitis
29 programs52 trialsApproved
Eosinophilic Esophagitis
360 programs16 trialsApproved
Respiratory Failure
158 programs14 trialsApproved
Sarcoidosis
42 programs16 trialsApproved
ARDS
0 programs54 trials
Pleural Effusion
42 programs11 trialsApproved
Chronic Cough
141 programs10 trialsApproved
Bronchopulmonary Dysplasia
237 programs12 trialsApproved
Chronic Rhinosinusitis With Nasal Polyps
231 programs17 trialsApproved
Pulmonary Sarcoidosis
33 programs7 trialsApproved
Severe Asthma
10 programs37 trialsPhase 3
Emphysema
129 programs5 trialsApproved
Alpha-1 Antitrypsin Deficiency
127 programs6 trialsPhase 3
Acute Respiratory Failure
123 programs6 trialsApproved
Atopic Asthma
20 programs0 trialsPhase 3
Chronic Lung Disease
17 programs1 trialApproved
Chronic Obstructive Pulmonary Disease (COPD)
70 programs18 trialsPhase 3
Showing top 30 diseases by activity. 129 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)